Diurnal Triglyceridemia in Relation to Alcohol Intake

This study has been completed.
Information provided by (Responsible Party):
Ana Torres do Rego, Sint Franciscus Gasthuis
ClinicalTrials.gov Identifier:
First received: January 29, 2013
Last updated: February 5, 2013
Last verified: February 2013
The purpose of this study is to determine the impact of alcohol consumption in diurnal triglyceridemia in a free living situation.

Healthy Subjects
Type 2 Diabetes Mellitus
Cardiovascular Diseases

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Observational Study of Diurnal Triglyceridemia in Relation to Alcohol Intake

Resource links provided by NLM:

Further study details as provided by Sint Franciscus Gasthuis:

Primary Outcome Measures:
  • Determination of diurnal triglyceridemia depend on alcohol intake [ Time Frame: For 3 days. ] [ Designated as safety issue: No ]
    Capillary triglyceridemia was measured by a triglyceride testing device on six fixed time-points.

Secondary Outcome Measures:
  • Gender differences in diurnal triglyceridemia by alcohol consumption [ Time Frame: For 3 days ] [ Designated as safety issue: No ]

Enrollment: 273
Primary Completion Date: December 2005 (Final data collection date for primary outcome measure)
General population
Healthy volunteers,patients with hyperlipidemia,a known medical history of cardiovascular diseases or type 2 diabetes mellitus.


Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Subjects were healthy volunteers or patients with hyperlipidemia or a known medical history of cardiovascular diseases, type 2 diabetes mellitus participating in several clinical studies with the same protocol, aimed to investigate factors influencing postprandial lipemia

Inclusion Criteria:

  • Healthy volunteers

Patients with:

  • Hyperlipidemia
  • Type 2 Diabetes Mellitus
  • Cardiovascular diseases

Exclusion Criteria:

  • Renal disease
  • Liver disease
  • Thyroid disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01786421

Sint Franciscus Gasthuis
Rotterdam, Netherlands, 10900
Utrecht University Medical Center
Utrecht, Netherlands
Sponsors and Collaborators
Sint Franciscus Gasthuis
  More Information

Responsible Party: Ana Torres do Rego, Medical Doctor, Sint Franciscus Gasthuis
ClinicalTrials.gov Identifier: NCT01786421     History of Changes
Other Study ID Numbers: AlcoholTG_SFG_2013 
Study First Received: January 29, 2013
Last Updated: February 5, 2013
Health Authority: Netherlands: Dutch Health Care Inspectorate

Keywords provided by Sint Franciscus Gasthuis:

Additional relevant MeSH terms:
Alcohol Drinking
Cardiovascular Diseases
Diabetes Mellitus, Type 2
Diabetes Mellitus
Drinking Behavior
Endocrine System Diseases
Glucose Metabolism Disorders
Lipid Metabolism Disorders
Metabolic Diseases

ClinicalTrials.gov processed this record on May 05, 2016